Literature DB >> 17885053

Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer.

Vikas Kundra1, Paul M Silverman, Surena F Matin, Haesun Choi.   

Abstract

OBJECTIVE: The purpose of this article is to discuss the epidemiology, risk factors, and presentation of prostate cancer. After reviewing the prostate anatomy, the article will show how imaging plays an important role in establishing the diagnosis, staging, and monitoring the therapeutic response in prostate cancer, with a focus on adenocarcinomas.
CONCLUSION: Imaging studies, in the appropriate laboratory and clinical context, contribute essential information that enhances the capacity to provide individualized risk stratification, a suitable treatment strategy, and monitoring for the patient with prostate cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17885053     DOI: 10.2214/AJR.07.2011

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

1.  Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT.

Authors:  David M Schuster; Bital Savir-Baruch; Peter T Nieh; Viraj A Master; Raghuveer K Halkar; Peter J Rossi; Melinda M Lewis; Jonathon A Nye; Weiping Yu; F DuBois Bowman; Mark M Goodman
Journal:  Radiology       Date:  2011-04-14       Impact factor: 11.105

2.  Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma.

Authors:  Bital Savir-Baruch; David M Schuster; Nashwa Jarkas; Viraj A Master; Peter T Nieh; Raghuveer K Halkar; Jonathon A Nye; Melinda M Lewis; Ronald J Crowe; Ronald J Voll; Vernon M Camp; Leah M Bellamy; David L Roberts; Mark M Goodman
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

3.  Magnetic resonance imaging for prostate cancer clinical application.

Authors:  Bing Li; Yong Du; Hanfeng Yang; Yayong Huang; Jun Meng; Dongmei Xiao
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

Review 4.  Multiparametric MRI in prostate cancer management.

Authors:  Linda M Johnson; Baris Turkbey; William D Figg; Peter L Choyke
Journal:  Nat Rev Clin Oncol       Date:  2014-05-20       Impact factor: 66.675

5.  Does intensity-modulated radiation therapy (IMRT) alter prostate size? Magnetic resonance imaging evaluation of patients undergoing IMRT alone.

Authors:  Hidekazu Tanaka; Takahiro Yamaguchi; Kae Hachiya; Masahide Hayashi; Shinichi Ogawa; Hironori Nishibori; Shingo Kamei; Satoshi Ishihara; Masayuki Matsuo
Journal:  Rep Pract Oncol Radiother       Date:  2017-09-19

6.  Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis.

Authors:  Cher Heng Tan; Wei Wei; Valen Johnson; Vikas Kundra
Journal:  AJR Am J Roentgenol       Date:  2012-10       Impact factor: 3.959

7.  Challenges in clinical prostate cancer: role of imaging.

Authors:  Gary J Kelloff; Peter Choyke; Donald S Coffey
Journal:  AJR Am J Roentgenol       Date:  2009-06       Impact factor: 3.959

8.  Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial.

Authors:  Eduard Schreibmann; David M Schuster; Peter J Rossi; Joseph Shelton; Sherrie Cooper; Ashesh B Jani
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-04-30       Impact factor: 7.038

9.  Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer.

Authors:  Rajakumar Nagarajan; Daniel Margolis; Steven Raman; Ke Sheng; Christopher King; Robert Reiter; M Albert Thomas
Journal:  Adv Urol       Date:  2011-12-15

10.  Metastasis of genitourinary tumors to the head and neck region.

Authors:  Ore Ogunyemi; A Rojas; K Hematpour; D Rogers; C Head; C Bennett
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-06-18       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.